Friday

24-10-2025 Vol 19

Vecima Networks declares $0.055 dividend

Business, News September 22, 2021

Vecima Networks declares $0.055 dividend

Avatar photo

Brian Kraut

Related Posts
March 02, 2021 Business, News by Brian Kraut

GameStop received’t cease Robinhood from launching its IPO bid

Robinhood may file for an IPO as quickly as this month. Good concept? Unhealthy concept? Read More
May 21, 2021 Business, News by Brian Kraut

Will the brief sellers come for Oatly?

Will the brief sellers come for Oatly? | Fortune It is advisable to allow JavaScript to view this website.
October 13, 2022 Business by Brian Kraut

Digital Scale Vs. Analog Scale: Which Is Better For Optimum Precision?

When choosing a weighing scale, you might be torn between using an analog or a digital scale. Here’s a quick…
July 23, 2021 Business, News by Brian Kraut

Silvergate (NYSE:FINV) Capital leads this week’s monetary gainers,

Silvergate Capital leads this week's monetary gainers, Lufax Holdings falls
January 24, 2022 Business, News by Brian Kraut

Southern States Bancshares Non-GAAP EPS of $0.47, income of $15.85M

Southern States Bancshares Non-GAAP EPS of $0.47, income of $15.85M
October 22, 2021 Business, News by Brian Kraut

Incyte enters into provide and distribution pact with Specialised Therapeutics

Incyte enters into provide and distribution pact with Specialised Therapeutics
June 23, 2021 Business, News by Brian Kraut

HP declares $0.1938 dividend (NYSE:HPQ)

HP declares $0.1938 dividend
December 09, 2022 Business by Brian Kraut

These First Date Venues Are Worth Trying; here’s Why

Many venues are worth trying for those seeking a unique and memorable first date. Here’s why: Popular tourist destinations like…
December 20, 2021 Business, News by Brian Kraut

First Hydrogen group up with FEV Consulting GMBH for improvement of hydrogen mobility ..

First Hydrogen group up with FEV Consulting GMBH for improvement of hydrogen mobility refueling stations
January 14, 2022 Business, News by Brian Kraut

Corvus Pharma initiates Part 1/1b trial of CPI-818 for T-cell lymphomas in China

Corvus Pharma initiates Part 1/1b trial of CPI-818 for T-cell lymphomas in China